To further investigate the relationship between CHEK2 and TP53-mutated HCC cells, we analyzed data from three cohorts (TCGA, ICGC, and GAO et al.)and found a significant upregulation of CHEK2 expression in tissues with TP53 mutations (Fig. 3A). Here, TP53 is linked to hepatocellular carcinoma.